Results 91 to 100 of about 1,971,842 (244)

A Painful Purpuric Rash in a Febrile Smoker

JEADV Clinical Practice, EarlyView.
Eugerta Dilka, Ina Sotiri, Irda Rrugeja, Monika Fida   +3 more
wiley   +1 more source

Th2/Th17 Inflammation: Pathogenic Drivers and Therapeutic Targets in Darier and Hailey‐Hailey Diseases

JEADV Clinical Practice, EarlyView.
Skin samples of Hailey‐Hailey and Darier diseases were analyzed for inflammatory and barrier markers using indirect immunofluorescence and transcriptomic techniques. A mixed Th2/Th17 inflammatory pattern and altered expression of barrier markers were observed.
Ella Glodjajic, Darko Stojkov, Joanna Boros‐Majewska, Jeremy Di Domizio, Michel Gilliet, Christoph Schlapbach, Timothée Fettrelet, Luca Borradori, Hans‐Uwe Simon, Dagmar Simon, Susanne Radonjic‐Hoesli   +10 more
wiley   +1 more source

Antondine Injection-Associated Fixed Drug Eruption: A Case Report

Clinical Medicine Insights: Case Reports
Background: Fixed drug eruption (FDE) is a drug hypersensitivity reaction caused by antibiotics and non-steroidal anti-inflammatory drugs primarily.
Yan Yang, Peng-Fei Li, Qiang Ma, Xiao-Na Wang, Qing Chen, Ling-Yun Ma, Hao Tang, Zhen Wang   +7 more
doaj   +1 more source

Levofloxacin-induced fixed drug eruption

Fixed drug eruption is a distinctive cutaneous adverse drug reaction characterised by the recurrence of well-demarcated lesions at the same anatomical site following re-exposure to the offending drug, with residual hyperpigmentation after resolution ...
Malay Jayantigiri Goswami, Rashmi Mahajan, Mahavir Singh Rajput, Shruti Vihang Brahmbhatt   +3 more
core   +1 more source

Chronic Pruritic Papular Eruption in an Elderly Man

JEADV Clinical Practice, EarlyView.
Filipe Monteiro, Inês Tribolet‐Abreu, Gustavo Almeida‐Silva, Inês Amaral, Ivânia Soares, Sónia Fernandes, Joana Antunes   +6 more
wiley   +1 more source

Real World Use of the IL‐36 Receptor Antagonist Spesolimab: A Systematic Review and Analysis

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Spesolimab, an interleukin‐36 receptor antagonist, is approved for the treatment and prevention of generalised pustular psoriasis (GPP) flares. Its use has increasingly been reported in real‐world settings for both GPP and other inflammatory dermatoses.
Sophia A. Mense, Nicole Bavaro, Aashna Farishta, Jiaqi Chen, Raj Chovatiya   +4 more
wiley   +1 more source

Fixed Eruptions: Drug, food, and what more?

Clinical Dermatology Review
Fixed drug eruption (FDE) is a common entity encountered in our day-to-day clinical practice. It is a T-cell-dependent pathway with induction of interferon-gamma-producing CD8+ T-cells in the dermis and epidermis.
Prabhakar Mallikarjuna Sangolli, Neethu Mary George   +1 more
doaj   +1 more source

Chlorzoxazone-Induced Fixed Drug Eruption: A Clinical Case Report [PDF]

Hend Alotaibi,1 Reem Alsergani,1 Amer Abdulaziz Alharbi,1 Khalid Nabil Nagshabandi,1 Asma Ahmed Almubark2 1Department of Dermatology, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 2College of Medicine, King Faisal University, Al-Ahsa ...
Alotaibi H, Alharbi AA, Alsergani R, Nagshabandi KN, Almubark AA   +4 more
core  

A first case of fixed drug eruption due to Tamsulosin

, 2020
Background: Fixed Drug Eruption (FDE) is a drug reaction involving the skin and less commonly the mucosal membranes. Tamsulosin is an alpha-1 adrenergic receptor blocker used to treat benign prostatic hyperplasia.
Nouripour, B., Ahmadi, A., Jahani Amiri, K., Montazer, F., Mofarrah, R.   +4 more
core  

Two Entities, One Patient

JEADV Clinical Practice, EarlyView.
Wael Zaina, Tomer Cohen, Judit Krausz, Michael Ziv, Roni P. Dodiuk‐Gad   +4 more
wiley   +1 more source